Anti-Aging news
Published in Biology, Diseases, General News.
Daily highlights from the world of longevity and healthspan:
An overview of how proposed The National Institutes of Health cuts could impact US geroscience funding at a critical time for the field.
Momentum for Parkinson’s innovation grows with Vincere Biosciences receiving a major The Michael J. Fox Foundation For Parkinson’s Research grant to push its mitophagy-promoting therapy toward first-in-human studies.
Ochre Bio and GSK complete comprehensive human liver functional genomics datasets, paving the way for new target discovery and stronger translational insights.
HCW Biologics kicks off its first-in-human trial of HCW9302, marking a key step forward in autoimmune disease therapeutics.
New Annovis Bio, Inc. data link Alzheimer’s co-pathology to faster cognitive decline in Parkinson’s – and show buntanetap may deliver stronger cognitive benefits in amyloid-positive patients.
With a January Type C meeting scheduled with the FDA, Annovis Bio, Inc. outlines next steps for buntanetap in Parkinson’s dementia and confirms Phase 3 readiness in Alzheimer’s.
Zymo Research Corp and biomodal team up to deliver integrated multi-omic sequencing, enabling genetic and epigenetic insights from a single sample.
Discover how Longevity Center | Europe is advancing science-driven, personalized health optimization in the heart of Warsaw, Poland – connecting diagnostics, prevention and performance into one integrated roadmap.
🔔 Keep up with the latest in longevity, every day. Check out all the latest news on our website. Link as first comment.